ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5,801 | 71.69299 | 0 | male | 0 | 13 | 348 | Colon Cancer | Cancer | 1 | 18 | >$50k | 9 | 30,518 | null | null | 26 | white | 16.5 | 16 | 0.78894 | 0.555908 | 1 | 0 | 0 | metastatic | null | null | no dnr | 13 | 112 | 11.398438 | 135 | 31 | 38.29688 | 145 | 3.099609 | 1.299805 | 0.799927 | 135 | 7.399414 | 133 | 12 | 1,220 | 0 | 0 | no(M2 and SIP pres) | 0 |
5,802 | 73.28699 | 0 | male | 0 | 6 | 348 | Colon Cancer | Cancer | 1 | 14 | null | 0 | 10,775 | null | null | 12 | white | 15.898438 | 4 | 0.816895 | 0.605957 | 1 | 0 | 0 | metastatic | 0.6 | 0.4 | no dnr | 6 | 118 | 8.298828 | 135 | 38 | 35.5 | 226.65625 | 2.399902 | 0.5 | 0.699951 | 128 | 7.319336 | 103 | 10 | 3,730 | 0 | null | no(M2 and SIP pres) | 0.494751 |
5,803 | 70.461 | 0 | male | 0 | 15 | 347 | Lung Cancer | Cancer | 2 | null | null | 0 | 15,315 | null | null | 9.333328 | white | 35.695313 | 39 | 0.189972 | 0.015999 | 1 | 0 | 0 | metastatic | 0.3 | 0.2 | dnr after sadm | 2 | 108 | 10.599609 | 65 | 16 | 38.09375 | null | null | null | 0.699951 | 138 | 7.429688 | 99 | 5 | 4,280 | 0 | 0 | adl>=4 (>=5 if sur) | 0 |
5,804 | 69.74896 | 1 | female | 1 | 29 | 29 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 10 | null | 0 | 213,137 | null | null | 45.5 | white | 26.796875 | 46 | 0.60791 | 0.501953 | 10 | 0 | 0 | yes | 0.5 | 0.5 | dnr after sadm | 28 | 50 | 3.199707 | 145 | 36 | 38.5 | 56.46875 | 2 | 0.899902 | 1.199951 | 142 | 7.25 | 94 | 11 | 1,696 | null | null | <2 mo. follow-up | 2.077637 |
5,805 | 51.13199 | 0 | male | 0 | 7 | 347 | MOSF w/Malig | ARF/MOSF | 2 | 0 | under $11k | 0 | 24,871 | null | null | 16.5 | white | 26.597656 | 34 | 0.613892 | 0.507935 | 4 | 0 | 0 | yes | null | null | no dnr | 7 | 103 | 7.799805 | 66 | 26 | 36.69531 | null | null | null | 0.699951 | 139 | null | 237 | 24 | 1,800 | null | 6 | adl>=4 (>=5 if sur) | 6 |
5,806 | 56.70898 | 1 | male | 1 | 43 | 43 | CHF | COPD/CHF/Cirrhosis | 2 | 9 | $11-$25k | 0 | 204,861 | null | null | 30 | white | 28 | 26 | 0.787964 | 0.660889 | 1 | 0 | 0 | no | 0.9 | 0.7 | dnr after sadm | 43 | 115 | 6.5 | 101 | 28 | 36.79688 | 177.5 | 2.599609 | 0.899902 | 0.899902 | 145 | 7.449219 | 87 | 21 | 1,700 | 0 | 0 | <2 mo. follow-up | 0 |
5,807 | 58.03998 | 1 | male | 0 | 8 | 141 | Colon Cancer | Cancer | 1 | 12 | null | 0 | 15,249 | null | null | 11.5 | black | 16.097656 | 21 | 0.839966 | 0.649902 | 1 | 0 | 0 | metastatic | 0.6 | 0.3 | no dnr | 8 | 83 | 7.799805 | 75 | 18 | 36.79688 | 304 | null | null | 0.899902 | 143 | 7.40918 | 125 | 23 | null | 3 | 1 | no(M2 and SIP pres) | 1 |
5,808 | 26.44199 | 0 | male | 0 | 19 | 346 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 10 | under $11k | 0 | 59,332 | null | null | 15 | black | 26.296875 | 35 | 0.849976 | 0.797974 | 10 | 0 | 0 | no | 0.8 | 0.75 | no dnr | 19 | 118 | 11.398438 | 75 | 8 | 36 | 316.625 | 1.899902 | 5.199219 | 1.299805 | 134 | 7.359375 | 176 | 25 | 1,325 | null | null | no(M2 and SIP pres) | 2.490723 |
5,809 | 45.71399 | 0 | female | 0 | 6 | 345 | Colon Cancer | Cancer | 2 | 12 | under $11k | 0 | 10,864 | null | null | 11 | black | 9.099609 | 6 | 0.917969 | 0.80896 | 1 | 0 | 0 | metastatic | null | null | no dnr | 6 | 118 | 11 | 145 | 24 | 35.89844 | 162.5 | null | 0.5 | 0.699951 | 135 | 7.439453 | 264 | 19 | 1,775 | 0 | 0 | no(M2 and SIP pres) | 0 |
5,810 | 65.89697 | 1 | male | 0 | 18 | 295 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 37 | 67,982 | null | null | 32.666657 | white | 63.5 | 51 | 0 | 0 | 3 | 0 | 0 | no | 0.4 | 0.2 | no dnr | 18 | 111 | 8.5 | 66 | 20 | 38.09375 | null | 4.199219 | 0.699951 | 0.799927 | 139 | null | 95 | 18 | null | null | null | no(M2 and SIP pres) | 1.852539 |
5,811 | 42.28598 | 1 | male | 0 | 32 | 39 | MOSF w/Malig | ARF/MOSF | 2 | 10 | null | 9 | 48,077 | null | null | 7.75 | black | 32.796875 | 37 | 0.360962 | 0.243988 | 2 | 0 | 0 | metastatic | 0.05 | 0 | dnr after sadm | 6 | 65 | 20 | 65 | 10 | 38.69531 | 191.40625 | 1.799805 | 3.799805 | 1.899902 | 144 | 7.419922 | 247 | 68 | 3,920 | null | 1 | <2 mo. follow-up | 1 |
5,812 | 47.33197 | 1 | male | 0 | 8 | 26 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 11 | $25-$50k | 0 | 24,074 | null | null | 19 | white | 19.796875 | 15 | 0.897949 | 0.860962 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 8 | 90 | 10.599609 | 105 | 12 | 36.39844 | 195.21875 | 3.299805 | 0.299988 | 0.899902 | 142 | 7.269531 | 110 | 20 | 860 | 0 | 0 | <2 mo. follow-up | 0 |
5,813 | 67.56995 | 1 | male | 0 | 20 | 55 | Colon Cancer | Cancer | 1 | null | >$50k | 0 | 21,601 | null | null | 8 | white | 16.199219 | 11 | 0.822998 | 0.61792 | 1 | 0 | 0 | metastatic | null | null | no dnr | 20 | 45 | 11.5 | 115 | 13 | 39.19531 | 124.4375 | 2.799805 | null | 0.899902 | 134 | 7.469727 | 141 | 18 | 3,810 | 0 | 0 | <2 mo. follow-up | 0 |
5,814 | 46.92697 | 1 | male | 1 | 8 | 8 | MOSF w/Malig | ARF/MOSF | 1 | 16 | >$50k | 37 | 61,115 | null | null | 33.5 | white | 24.597656 | 44 | 0.362976 | 0.245972 | 13 | 0 | 0 | metastatic | null | null | no dnr | 8 | 72 | 6.799805 | 125 | 8 | 38.79688 | 230 | 2.5 | null | 1 | 137 | 7.359375 | 89 | 6 | 1,910 | null | null | <2 mo. follow-up | 2.751953 |
5,815 | 83.10699 | 1 | female | 1 | 35 | 35 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 4 | under $11k | 26 | 141,681 | null | null | 36 | black | 34.59375 | 51 | 0.164978 | 0.081985 | 12 | 0 | 0 | yes | 0.6 | 0.6 | dnr after sadm | 10 | 99 | 9.898438 | 76 | 20 | 36.39844 | 332 | null | null | 0.899902 | 136 | 7.399414 | 131 | 21 | 650 | null | 2 | <2 mo. follow-up | 2 |
5,816 | 61.26999 | 1 | male | 0 | 6 | 377 | Lung Cancer | Cancer | 2 | 10 | $25-$50k | 0 | 3,754 | 2,838.4238 | 800.45996 | 18 | white | 21.898438 | 26 | 0.60791 | 0.291992 | 1 | 0 | 0 | metastatic | 0.9 | 0.8 | no dnr | 6 | 73 | 5.799805 | 100 | 28 | 35.39844 | null | null | null | 0.799927 | 134 | null | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
5,817 | 51.836 | 0 | female | 0 | 8 | 2,029 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 5,572 | 4,188.9023 | 1,291.21973 | 7.5 | white | 15.898438 | 15 | 0.876953 | 0.795898 | 1 | 0 | 0 | no | 0.75 | 0.5 | no dnr | 8 | 93 | 3.5 | 80 | 26 | 36.39844 | 369 | 3 | 0.299988 | 0.699951 | 138 | 7.339844 | null | null | null | 1 | 0 | SIP>=30 | 0 |
5,818 | 30.04799 | 1 | female | 0 | 36 | 540 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 15 | under $11k | 44 | 40,193 | 30,074.125 | 10,792.5156 | 30.25 | white | 22.398438 | 20 | 0.823975 | 0.764893 | 2 | 0 | 0 | no | 0.75 | 0.5 | no dnr | 36 | 68 | 8.898438 | 116 | 7 | 36 | 246.46875 | 2.699707 | 0.5 | 0.5 | 135 | 7.449219 | null | null | null | null | 7 | adl>=4 (>=5 if sur) | 7 |
5,819 | 56.88397 | 0 | female | 0 | 18 | 2,026 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | $11-$25k | 9 | 38,938 | 30,539.2812 | 10,389.9453 | 36.333313 | white | 32.195313 | 49 | 0.571899 | 0.460999 | 2 | 0 | 0 | yes | 0.5 | 0.5 | no dnr | 18 | 137 | 10.298828 | 157 | 13 | 38.09375 | 88 | 2.599609 | 1.299805 | 0.599976 | 134 | 7.429688 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
5,820 | 49.20499 | 1 | female | 0 | 7 | 24 | CHF | COPD/CHF/Cirrhosis | 4 | 10 | under $11k | 0 | 5,771 | 4,279.543 | 1,743.22949 | 7.5 | other | 25.898438 | 29 | 0.844971 | 0.744995 | 1 | 1 | 0 | no | 0.1 | 0.001 | no dnr | 7 | 67 | 11.199219 | 104 | 26 | 35.79688 | 391.375 | 3.099609 | 1.5 | 0.899902 | 133 | 7.489258 | null | null | null | 1 | 5 | <2 mo. follow-up | 5 |
5,821 | 34.98398 | 1 | male | 0 | 5 | 31 | CHF | COPD/CHF/Cirrhosis | 3 | 11 | $11-$25k | 0 | 6,339 | 4,722.0547 | 1,178.40918 | 15 | black | 18.796875 | 31 | 0.932983 | 0.885986 | 1 | 1 | 0 | no | 0.95 | 0.95 | no dnr | 5 | 73 | 10.199219 | 105 | 32 | 36.59375 | 409.5 | 3.599609 | 0.399963 | 1.299805 | 136 | 7.419922 | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
5,822 | 64.64899 | 1 | male | 1 | 4 | 4 | Coma | Coma | 4 | null | null | 100 | 11,802 | 8,355.5938 | 4,095.76953 | 41 | white | 31.796875 | 38 | 0.014 | 0.004999 | 3 | 0 | 0 | yes | 0 | 0 | dnr after sadm | 4 | 57 | 33.59375 | 103 | 12 | 39.59375 | 135 | null | null | 2.199707 | 138 | 7.449219 | null | null | null | null | null | <2 mo. follow-up | 3.930176 |
5,823 | 40.44397 | 1 | male | 0 | 16 | 325 | Cirrhosis | COPD/CHF/Cirrhosis | 4 | 12 | $11-$25k | 0 | 11,137 | 8,525.7734 | 2,284.03906 | 8 | white | 21.398438 | 36 | 0.863892 | 0.773926 | 1 | 0 | 0 | no | 0.9 | 0.7 | no dnr | 16 | 96 | 8.099609 | 84 | 20 | 39 | null | 1.899902 | 8.798828 | 0.599976 | 135 | null | null | null | null | 1 | 1 | no(M2 and SIP pres) | 1 |
5,824 | 40.55899 | 1 | female | 0 | 15 | 586 | Cirrhosis | COPD/CHF/Cirrhosis | 6 | 12 | under $11k | 0 | 15,201 | 12,027.7031 | 2,170.59961 | 15 | black | 23.398438 | 47 | 0.829956 | 0.721924 | 2 | 0 | 0 | no | 0.8 | 0.5 | no dnr | 15 | 145 | 5.599609 | 82 | 30 | 36 | 336.0625 | 2.899902 | 3.099609 | 8.398438 | 135 | 7.399414 | null | null | null | 0 | 0 | SIP>=30 | 0 |
5,825 | 42.71597 | 1 | male | 0 | 6 | 791 | CHF | COPD/CHF/Cirrhosis | 2 | 6 | under $11k | 0 | 4,538 | 3,398.3379 | 1,333.5293 | 14 | white | 22.796875 | 15 | 0.891968 | 0.81897 | 1 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 6 | 97 | 11.398438 | 115 | 22 | 36 | 457.125 | 3.599609 | 0.799927 | 1.199951 | 131 | 7.40918 | null | null | null | 5 | 5 | adl>=4 (>=5 if sur) | 5 |
5,826 | 30.407 | 1 | male | 0 | 27 | 230 | MOSF w/Malig | ARF/MOSF | 2 | 12 | $11-$25k | 0 | 138,207 | 98,951.75 | 55,267.5 | 41.75 | black | 42.898438 | 83 | 0.131989 | 0.059998 | 43 | 0 | 0 | yes | 0.3 | 0.1 | no dnr | 27 | 107 | 0.319946 | 176 | 32 | 39.59375 | 147.125 | 3.799805 | 2.099609 | 3.099609 | 135 | 7.379883 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
5,827 | 67.409 | 1 | male | 0 | 8 | 15 | MOSF w/Malig | ARF/MOSF | 1 | 12 | under $11k | 0 | 5,608 | 4,262.5117 | 1,240.75977 | 7.5 | black | 31.398438 | 51 | 0.429993 | 0.309998 | 1 | 0 | 0 | metastatic | 0.1 | 0.001 | dnr after sadm | 2 | 97 | 17.898438 | 114 | 36 | 36.29688 | 430.4375 | 2.699707 | 1.799805 | 2.299805 | 130 | 7.209961 | null | null | null | null | null | <2 mo. follow-up | 3.778809 |
5,828 | 62.49698 | 1 | female | 1 | 79 | 79 | ARF/MOSF w/Sepsis | ARF/MOSF | 5 | 8 | null | 0 | 151,172 | 113,714.812 | 36,978 | 31 | white | 32.398438 | 47 | 0.482971 | 0.36499 | 23 | 1 | 0 | yes | 0.25 | 0.2 | dnr after sadm | 22 | 114 | 17.597656 | 68 | 32 | 36.5 | 85.625 | null | null | 2.199707 | 133 | 7.429688 | null | null | null | null | 3 | SIP>=30 | 3 |
5,829 | 44.32898 | 1 | female | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 14 | null | 9 | 21,020 | 16,124.1562 | 6,786.53906 | 50 | white | 28.898438 | 48 | 0.784912 | 0.714966 | 1 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 7 | 70 | 25.296875 | 111 | 22 | 38.5 | 109.5625 | 2.599609 | 0.399963 | 1.699951 | 133 | 7.389648 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
5,830 | 37.84 | 0 | male | 0 | 15 | 2,019 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 17 | under $11k | 0 | 26,070 | 19,550.6719 | 7,092.08984 | 31.666656 | white | 30.898438 | 45 | 0.800903 | 0.734985 | 1 | 1 | 0 | no | 0.75 | 0.75 | no dnr | 15 | 113 | 9.199219 | 118 | 20 | 35.39844 | 254.53125 | 2 | 6.399414 | 0.899902 | 128 | 7.399414 | null | null | null | null | 0 | null | 0 |
5,831 | 40.29797 | 1 | female | 0 | 16 | 94 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 14,205 | 10,412.1328 | 4,452.14844 | 12.666664 | white | 22.597656 | 35 | 0.851929 | 0.755981 | 1 | 0 | 0 | no | 0.8 | 0.5 | no dnr | 16 | 61 | 5 | 102 | 20 | 36.69531 | 375.6875 | 4.599609 | 1.899902 | 1.5 | 129 | 7.449219 | null | null | null | 2 | 4 | SIP>=30 | 4 |
5,832 | 79.69299 | 1 | male | 0 | 40 | 174 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | null | 0 | 109,357 | 78,708.625 | 31,970.1406 | 30 | white | 30.5 | 57 | 0.501953 | 0.384949 | 26 | 0 | 0 | no | 0.3 | 0.25 | no dnr | 40 | 110 | 11 | 127 | 11 | 39.19531 | 305 | 1.899902 | 5.199219 | 2.299805 | 133 | 7.459961 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
5,833 | 35.49899 | 1 | female | 1 | 9 | 9 | MOSF w/Malig | ARF/MOSF | 1 | 18 | $25-$50k | 44 | 32,652 | 24,079.4688 | 11,113.3984 | 52 | white | 42 | 77 | 0.023998 | 0.006 | 4 | 0 | 0 | metastatic | 0.05 | 0.000125 | no dnr | 9 | 54 | 3.199707 | 176 | 60 | 40 | 98.59375 | 2.599609 | 1.099854 | 0.899902 | 145 | 7.289062 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
5,834 | 77.30896 | 1 | male | 0 | 18 | 237 | Colon Cancer | Cancer | 1 | 12 | >$50k | 0 | 12,567 | 9,706.6719 | 2,523.81836 | 9.333328 | white | 15.199219 | 22 | 0.81897 | 0.608887 | 1 | 0 | 0 | metastatic | 1 | 0.5 | no dnr | 18 | 103 | 7.099609 | 60 | 20 | 36.59375 | null | 3.099609 | 0.799927 | 1.399902 | 133 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
5,835 | 67.64099 | 1 | male | 0 | 5 | 35 | Lung Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 3,671 | 2,911.4199 | 1,238 | 1 | white | 18 | 16 | 0.679932 | 0.384949 | 1 | 0 | 0 | metastatic | 0.25 | 0.01 | dnr after sadm | 1 | 95 | 3.899902 | 92 | 28 | 35.79688 | null | null | null | 1 | 141 | null | null | null | null | 0 | 2 | <2 mo. follow-up | 2 |
5,836 | 62.56497 | 0 | male | 0 | 4 | 2,016 | COPD | COPD/CHF/Cirrhosis | 2 | 3 | under $11k | 0 | 2,928 | 2,173.5625 | 929.50977 | 11 | white | 14.099609 | 28 | 0.899902 | 0.831909 | 1 | 0 | 0 | yes | 0.95 | 0.9 | no dnr | 4 | 98 | 7.599609 | 100 | 28 | 36.19531 | 273.75 | 4.099609 | 0.299988 | 1.099854 | 138 | 7.229492 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
5,837 | 55.66898 | 1 | male | 0 | 4 | 400 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | under $11k | 0 | 3,072 | 2,277.4668 | 1,010.32959 | 13 | white | 14.099609 | 19 | 0.927979 | 0.876953 | 1 | 1 | 0 | no | 0.9 | 0.75 | no dnr | 4 | 75 | 8 | 76 | 22 | 36.29688 | 284.75 | null | 0.5 | 1.199951 | 142 | 7.429688 | null | null | null | 0 | null | no(M2 and SIP pres) | 0.4948 |
5,838 | 64.70099 | 1 | female | 0 | 18 | 70 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 30,035 | 23,424.5625 | 10,360.9375 | 25.333328 | white | 38.296875 | 57 | 0.333984 | 0.218994 | 1 | 0 | 0 | metastatic | 0.4 | 0.2 | no dnr | 18 | 72 | 2.699707 | 128 | 28 | 36 | 199.625 | 3 | 1 | 3.199707 | 131 | 7.429688 | null | null | null | null | null | null | 3.917481 |
5,839 | 69.37195 | 1 | female | 1 | 17 | 17 | Lung Cancer | Cancer | 3 | null | null | 0 | 13,583 | 10,518.6953 | 3,508.4082 | 7.333332 | black | 30.796875 | 29 | 0.302979 | 0.051994 | 2 | 1 | 0 | metastatic | 0.5 | 0.1 | dnr after sadm | 4 | 83 | 10.699219 | 110 | 28 | 36.19531 | 466.625 | 2.599609 | 0.599976 | 1.099854 | 138 | 7.389648 | null | null | null | null | null | <2 mo. follow-up | 4.43457 |
5,840 | 78.35498 | 1 | male | 0 | 5 | 291 | CHF | COPD/CHF/Cirrhosis | 5 | 6 | under $11k | 0 | 4,032 | 2,952.9238 | 1,376.08984 | 7 | white | 27.597656 | 35 | 0.625 | 0.440979 | 1 | 1 | 0 | yes | 0.5 | 0.2 | dnr after sadm | 1 | 73 | 15.898438 | 120 | 24 | 36 | null | 3.199707 | 1 | 1.599854 | 132 | null | null | null | null | 6 | 3 | SIP>=30 | 3 |
5,841 | 24.931 | 0 | male | 0 | 22 | 2,014 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | under $11k | 0 | 41,978 | null | null | 34 | white | 39.296875 | 39 | 0.709961 | 0.621948 | 1 | 0 | 0 | no | 0.99 | 0.99 | no dnr | 22 | 51 | 21 | 46 | 10 | 35.69531 | 87.5625 | null | null | 0.5 | 135 | 7.459961 | null | null | null | null | 6 | SIP>=30 | 6 |
5,842 | 67.32898 | 1 | female | 0 | 17 | 145 | CHF | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 10,263 | 8,112.8359 | 1,359.84961 | 7 | white | 20.898438 | 37 | 0.843994 | 0.744995 | 1 | 1 | 0 | no | 0.6 | 0.6 | no dnr | 17 | 60 | 4.599609 | 58 | 20 | 36.19531 | null | null | 0.5 | 2.199707 | 135 | null | null | null | null | null | null | null | 3.324219 |
5,843 | 56.35599 | 0 | male | 0 | 4 | 2,012 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 6,956 | 5,181.9805 | 1,674.44922 | 7 | white | 15.599609 | 13 | 0.906982 | 0.842896 | 3 | 0 | 0 | no | null | null | no dnr | 4 | 79 | 5 | 68 | 16 | 36.39844 | null | null | null | 1 | 134 | null | null | null | null | 2 | null | null | 1.839 |
5,844 | 28.435 | 0 | male | 0 | 19 | 2,011 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 10 | under $11k | 0 | 28,546 | 21,811.0938 | 7,453.73828 | 26 | white | 20.699219 | 23 | 0.911987 | 0.879883 | 3 | 1 | 0 | no | 0.8 | 0.8 | no dnr | 19 | 135 | 8.298828 | 126 | 10 | 36.69531 | 200 | 3.299805 | 0.5 | 0.699951 | 137 | 7.429688 | null | null | null | null | 6 | no(M2 and SIP pres) | 6 |
5,845 | 44.74698 | 1 | female | 1 | 13 | 13 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $11-$25k | 0 | 62,724 | 44,182.9062 | 27,231.3438 | 54.5 | white | 35.695313 | 56 | 0.631958 | 0.529907 | 5 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 13 | 70 | 19 | 149 | 27 | 39.69531 | 75.70312 | 2.299805 | 1.599854 | 1.599854 | 147 | 7.449219 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
5,846 | 68.90094 | 1 | male | 0 | 14 | 21 | Colon Cancer | Cancer | 1 | 10 | under $11k | 0 | 51,678 | 39,554.6562 | 16,607.25 | 21.666656 | white | 37.5 | 23 | 0.194977 | 0.017998 | 42 | 0 | 0 | metastatic | 0.75 | 0.5 | no dnr | 14 | 73 | 4.899414 | 94 | 20 | 36.59375 | null | 2 | 1.099854 | 0.599976 | 129 | null | null | null | null | 1 | 6 | <2 mo. follow-up | 6 |
5,847 | 68.48199 | 0 | male | 0 | 22 | 2,010 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | $11-$25k | 0 | 48,631 | 36,397.8125 | 18,265.7344 | 32 | white | 22.898438 | 40 | 0.702881 | 0.612915 | 10 | 0 | 0 | yes | 0.9 | 0.9 | no dnr | 22 | 53 | 13.398438 | 71 | 10 | 36.5 | 262.9375 | 1.899902 | 0.199982 | 1.699951 | 135 | 7.399414 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
5,848 | 60.52298 | 1 | male | 1 | 11 | 11 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 6 | null | 55 | 25,975 | 20,341.9688 | 5,722.01953 | 37.5 | white | 18.597656 | 30 | 0.756958 | 0.678955 | 1 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 11 | 124 | 7 | 115 | 25 | 38.19531 | 304 | 2.799805 | 0.5 | 0.899902 | 135 | 7.459961 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
5,849 | 28.55899 | 1 | female | 1 | 138 | 138 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | under $11k | 61 | 94,804 | 197,694 | 78,501.1875 | 44.25 | black | 23.5 | 30 | 0.698975 | 0.608887 | 52 | 0 | 0 | no | 1 | 0.5 | dnr after sadm | 62 | 78 | 33.09375 | 127 | 36 | 38.39844 | 212.5 | 2.799805 | 0.299988 | 0.699951 | 142 | 7.469727 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
5,850 | 71.93195 | 1 | male | 1 | 8 | 8 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | $11-$25k | 26 | 20,133 | 13,816.5078 | 8,076.78906 | 59 | white | 46 | 68 | 0.118988 | 0.051994 | 1 | 0 | 0 | no | null | null | dnr after sadm | 6 | 36 | 17 | 187 | 14 | 37.59375 | 103.1875 | 3.299805 | 1.099854 | 1.699951 | 142 | 7.419922 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
5,851 | 61.78497 | 0 | female | 0 | 37 | 2,007 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | $11-$25k | 41 | 42,011 | 36,107.4062 | 13,650.8047 | 36 | white | 35.695313 | 37 | 0.391968 | 0.272949 | 1 | 0 | 0 | no | 0.1 | 0.001 | no dnr | 37 | 44 | 10.898438 | 116 | 40 | 37.79688 | 210.4375 | 3 | 0.899902 | 0.5 | 135 | 7.519531 | null | null | null | null | 6 | null | 6 |
5,852 | 19.82999 | 0 | male | 0 | 47 | 2,005 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 11 | under $11k | 0 | 88,468 | 66,124.5 | 30,963.5 | 28 | white | 27.296875 | 58 | 0.859985 | 0.810913 | 8 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 47 | 73 | 31.5 | 111 | 43 | 38.59375 | 240 | 1.799805 | 4.699219 | 1.599854 | 135 | 7.419922 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
5,853 | 41.78 | 1 | female | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | under $11k | 37 | 23,366 | 16,430.8281 | 9,346.36719 | 54 | white | 32.398438 | 67 | 0.542969 | 0.428955 | 10 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 5 | 61 | 29.199219 | 115 | 12 | 40.5 | 182.59375 | 0.799927 | 2.399902 | 2.699707 | 133 | 7.459961 | null | null | null | null | 2 | <2 mo. follow-up | 2 |
5,854 | 32.81 | 1 | male | 1 | 8 | 8 | Cirrhosis | COPD/CHF/Cirrhosis | 4 | null | null | 0 | 22,651 | null | null | 55.5 | other | 26.597656 | 32 | 0.837891 | 0.734985 | 1 | 0 | 0 | no | 0.6 | 0.4 | no dnr | 8 | 123 | 9.898438 | 136 | 30 | 35.89844 | null | 2.5 | 2.699707 | 0.599976 | 137 | null | null | null | null | null | null | <2 mo. follow-up | 3.158203 |
5,855 | 71.67999 | 1 | female | 0 | 6 | 295 | CHF | COPD/CHF/Cirrhosis | 4 | 11 | under $11k | 0 | 4,250 | 3,164.7832 | 1,135.85938 | 7 | white | 20.597656 | 33 | 0.794922 | 0.669922 | 1 | 0 | 0 | yes | 0.8 | 0.6 | no dnr | 6 | 77 | 7.5 | 136 | 30 | 38.39844 | null | 3.399902 | 0.899902 | 1 | 134 | null | null | null | null | 1 | 2 | SIP>=30 | 2 |
5,856 | 69.06494 | 1 | female | 0 | 35 | 316 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | under $11k | 0 | 51,892 | 38,072 | 11,698.5391 | 23.5 | white | 36.09375 | 43 | 0.54895 | 0.350952 | 1 | 0 | 0 | no | 0.7 | 0.5 | no dnr | 35 | 63 | 7.699219 | 52 | 18 | 35.29688 | 257.75 | 2.699707 | 5 | 1.799805 | 121 | 7.449219 | null | null | null | null | null | null | 3.983887 |
5,857 | 47.31 | 1 | male | 0 | 4 | 75 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 11 | under $11k | 0 | 2,390 | 1,865.4102 | 616.91992 | 10 | white | 28.796875 | 31 | 0.720947 | 0.564941 | 1 | 0 | 0 | no | 0.25 | 0.1 | no dnr | 4 | 63 | 10.898438 | 70 | 20 | 36 | 351.375 | 2.699707 | 1.5 | 2.299805 | 123 | 7.359375 | null | null | null | 4 | 4 | adl>=4 (>=5 if sur) | 4 |
5,858 | 44.34497 | 0 | male | 0 | 4 | 2,002 | Cirrhosis | COPD/CHF/Cirrhosis | 5 | 12 | under $11k | 0 | 3,131 | 2,288.5469 | 1,054.86914 | 3 | white | 25.199219 | 33 | 0.799927 | 0.677979 | 1 | 0 | 0 | no | 0.9 | 0.5 | no dnr | 4 | 65 | 9.599609 | 110 | 22 | 36.79688 | null | 2.199707 | 5.099609 | 1 | 129 | null | null | null | null | 2 | 3 | no(M2 and SIP pres) | 3 |
5,859 | 61.28998 | 1 | male | 0 | 14 | 92 | COPD | COPD/CHF/Cirrhosis | 4 | 9 | under $11k | 0 | 11,336 | 8,405.0625 | 3,265.48828 | 13 | black | 37.59375 | 74 | 0.586914 | 0.394958 | 1 | 0 | 0 | no | 0.8 | 0.4 | no dnr | 14 | 79 | 7.599609 | 110 | 36 | 35.79688 | 59.58594 | 3.699707 | 3.5 | 1.799805 | 144 | 7.199219 | null | null | null | 1 | null | no(M2 and SIP pres) | 1.1669 |
5,860 | 71.52899 | 1 | female | 0 | 6 | 62 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 9 | null | 0 | 7,352 | 5,145.6758 | 2,710.29883 | 36 | black | 29.5 | 59 | 0.684937 | 0.591919 | 1 | 0 | 0 | no | 0.5 | 0.4 | no dnr | 6 | 157 | 14.099609 | 155 | 34 | 36.79688 | 302.625 | 3.299805 | 1 | 4.299805 | 141 | 7.379883 | null | null | null | null | null | adl>=4 (>=5 if sur) | 2.599121 |
5,861 | 55.159 | 1 | female | 1 | 3 | 3 | MOSF w/Malig | ARF/MOSF | 2 | 8 | $11-$25k | 100 | 8,871 | 6,550.4883 | 2,963.44922 | 17 | black | 69.6875 | 66 | 0 | 0 | 8 | 0 | 0 | metastatic | 0 | 0 | dnr after sadm | 2 | 0 | 21.5 | 0 | 0 | 38.19531 | 311.875 | null | null | 0.599976 | 145 | 7.40918 | null | null | null | null | null | <2 mo. follow-up | 3.336426 |
5,862 | 58.431 | 1 | female | 0 | 6 | 218 | CHF | COPD/CHF/Cirrhosis | 7 | 12 | under $11k | 0 | 8,990 | 6,529.2305 | 2,535.00977 | 23 | white | 26.898438 | 43 | 0.79895 | 0.675903 | 1 | 0 | 0 | no | 1 | 1 | no dnr | 6 | 60 | 16.296875 | 75 | 24 | 37.69531 | 203.65625 | 3.899902 | 0.899902 | 7.199219 | 121 | 7.5 | null | null | null | null | 2 | SIP>=30 | 2 |
5,863 | 68.20496 | 1 | male | 0 | 9 | 399 | Colon Cancer | Cancer | 3 | 15 | $25-$50k | 0 | 6,141 | 4,727.3555 | 1,450.80957 | 7.5 | white | 21.898438 | 32 | 0.731934 | 0.460999 | 1 | 1 | 0 | metastatic | 0.9 | 0.7 | no dnr | 9 | 75 | 10.5 | 56 | 16 | 36.39844 | null | null | null | 2.099609 | 135 | null | null | null | null | 1 | 0 | no(M2 and SIP pres) | 0 |
5,864 | 31.95299 | 1 | female | 1 | 91 | 91 | Coma | Coma | 1 | 10 | under $11k | 100 | 119,299 | 89,641.0625 | 28,174.3281 | 29.5 | hispanic | 27.097656 | 30 | 0.452942 | 0.379944 | 1 | 0 | 0 | no | 0.65 | 0.6 | dnr after sadm | 46 | 69 | 15.199219 | 126 | 24 | 38.09375 | 132 | 2.599609 | 3.299805 | 1.099854 | 143 | 7.349609 | null | null | null | null | 7 | adl>=4 (>=5 if sur) | 7 |
5,865 | 36.62698 | 1 | male | 0 | 7 | 1,338 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | null | null | 0 | 8,429 | 6,005.6445 | 3,148.72852 | 10 | white | 21.097656 | 22 | 0.906982 | 0.872925 | 1 | 1 | 1 | no | 0.95 | 0.95 | no dnr | 7 | 68 | 6.5 | 68 | 20 | 35.79688 | 514.25 | 2.799805 | 0.399963 | 0.599976 | 130 | 7.429688 | null | null | null | null | null | null | 5.543945 |
5,866 | 46.05298 | 1 | female | 1 | 4 | 4 | Lung Cancer | Cancer | 1 | null | null | 0 | 3,829 | 2,781.1406 | 1,602.76953 | 21 | black | 24.199219 | 24 | 0.596924 | 0.277954 | 1 | 0 | 0 | metastatic | null | null | no dnr | 4 | 108 | 10.398438 | 122 | 28 | 37.5 | null | 3.099609 | 0.5 | 1 | 141 | null | null | null | null | null | null | <2 mo. follow-up | 2.757324 |
5,867 | 49.26797 | 1 | female | 1 | 11 | 11 | MOSF w/Malig | ARF/MOSF | 2 | 12 | under $11k | 0 | 10,142 | 7,426.9219 | 3,350.51953 | 19.5 | white | 42.195313 | 73 | 0.15799 | 0.076996 | 1 | 1 | 0 | metastatic | null | null | dnr after sadm | 2 | 47 | 10.898438 | 51 | 44 | 34.09375 | 251.65625 | 2.599609 | 1.899902 | 2.399902 | 133 | 7.229492 | null | null | null | null | null | <2 mo. follow-up | 4.105469 |
5,868 | 64.88196 | 1 | male | 1 | 16 | 16 | Colon Cancer | Cancer | 1 | 10 | $11-$25k | 0 | 14,860 | 11,180.2422 | 4,777.23828 | 20.333328 | white | 42.296875 | 32 | 0.20697 | 0.019997 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 13 | 73 | 13.099609 | 75 | 26 | 35 | null | 1.599854 | 1.099854 | 0.5 | 133 | null | null | null | null | 4 | null | <2 mo. follow-up | 3.183199 |
5,869 | 87.64697 | 1 | female | 0 | 12 | 28 | MOSF w/Malig | ARF/MOSF | 1 | 8 | under $11k | 0 | 8,111 | 6,287.2188 | 1,623.80957 | 15.5 | white | 29.398438 | 40 | 0.448975 | 0.328979 | 1 | 0 | 0 | metastatic | 0.2 | 0 | dnr before sadm | 0 | 104 | 10.599609 | 109 | 28 | 36.5 | 159.15625 | 2.699707 | 0.399963 | 2 | 133 | 7.379883 | null | null | null | 0 | 6 | <2 mo. follow-up | 6 |
5,870 | 50.46997 | 1 | female | 0 | 6 | 1,254 | MOSF w/Malig | ARF/MOSF | 4 | 12 | under $11k | 0 | 5,985 | 4,367.8477 | 2,013.09961 | 14 | white | 25.796875 | 38 | 0.611938 | 0.505981 | 1 | 0 | 0 | metastatic | 0.9 | 0.9 | no dnr | 6 | 63 | 2.199707 | 90 | 20 | 38.39844 | null | 4.099609 | 4 | 1.799805 | 136 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
5,871 | 67.19495 | 1 | male | 0 | 22 | 661 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | under $11k | 0 | 161,730 | 125,781.938 | 34,366.0625 | 24.666656 | black | 27.199219 | 33 | 0.650879 | 0.55188 | 53 | 0 | 0 | no | 0.4 | 0.3 | no dnr | 22 | 76 | 20.296875 | 150 | 9 | 35.79688 | 300 | 2.799805 | 0.5 | 0.799927 | 129 | 7.439453 | null | null | null | 1 | 6 | adl>=4 (>=5 if sur) | 6 |
5,872 | 78.724 | 0 | female | 0 | 61 | 1,994 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 9 | 83,082 | 64,754.0625 | 16,091.625 | 33 | white | 24.796875 | 42 | 0.711914 | 0.552979 | 1 | 0 | 0 | no | 0.7 | 0.6 | no dnr | 61 | 72 | 7.199219 | 63 | 29 | 36.39844 | 168.15625 | 3.099609 | 0.399963 | 0.699951 | 136 | 7.419922 | null | null | null | null | 6 | no(M2 and SIP pres) | 6 |
5,873 | 48.45999 | 1 | female | 0 | 17 | 167 | Cirrhosis | COPD/CHF/Cirrhosis | 4 | null | null | 0 | 18,182 | 13,137.2734 | 6,702.25781 | 11.333328 | white | 21.398438 | 18 | 0.829956 | 0.7229 | 1 | 0 | 0 | no | 0.8 | 0.5 | no dnr | 17 | 91 | 6.5 | 105 | 20 | 36.5 | 338.0625 | 2.799805 | 4.599609 | 1 | 134 | 7.429688 | null | null | null | 1 | null | SIP>=30 | 1.1669 |
5,874 | 55.66599 | 0 | female | 0 | 6 | 1,993 | CHF | COPD/CHF/Cirrhosis | 4 | 12 | under $11k | 0 | 4,172 | 3,183.1231 | 1,263.95996 | 10 | black | 17.5 | 18 | 0.905884 | 0.840942 | 1 | 1 | 0 | no | 1 | 1 | no dnr | 6 | 113 | 6.599609 | 70 | 23 | 35.79688 | null | 3.099609 | 0.299988 | 1.199951 | 134 | null | null | null | null | 1 | 2 | no(M2 and SIP pres) | 2 |
5,875 | 57.35797 | 1 | female | 0 | 9 | 1,814 | COPD | COPD/CHF/Cirrhosis | 3 | 9 | under $11k | 0 | 6,204 | 4,697.7812 | 1,339.28906 | 15 | white | 18.898438 | 19 | 0.902954 | 0.836914 | 1 | 0 | 0 | no | 0.75 | 0.75 | no dnr | 9 | 124 | 13 | 96 | 24 | 36.59375 | 232.25 | null | null | 1.399902 | 134 | 7.379883 | null | null | null | 5 | 2 | SIP>=30 | 2 |
5,876 | 78.54297 | 1 | male | 0 | 6 | 39 | COPD | COPD/CHF/Cirrhosis | 3 | 14 | under $11k | 0 | 4,418 | 3,298.2129 | 1,180.86914 | 6 | white | 33.09375 | 43 | 0.510986 | 0.309998 | 1 | 0 | 0 | no | 0.7 | 0.4 | dnr after sadm | 1 | 54 | 11 | 55 | 26 | 35.09375 | 101.65625 | 3.699707 | 0.699951 | 1.099854 | 147 | 7.399414 | null | null | null | 3 | null | <2 mo. follow-up | 2.511099 |
5,877 | 61.142 | 1 | male | 0 | 17 | 149 | COPD | COPD/CHF/Cirrhosis | 3 | 7 | under $11k | 0 | 26,263 | 19,732.5938 | 6,635.56641 | 13.666664 | black | 27.597656 | 33 | 0.736938 | 0.587891 | 8 | 0 | 0 | no | 0.8 | 0.9 | no dnr | 17 | 108 | 18.398438 | 116 | 34 | 36.39844 | 163.6875 | 3.399902 | 0.5 | 1.199951 | 132 | 7.399414 | null | null | null | 1 | 0 | SIP>=30 | 0 |
5,878 | 54.43698 | 1 | male | 0 | 5 | 75 | Lung Cancer | Cancer | 1 | 12 | $11-$25k | 0 | 3,960 | 3,163.5859 | 1,596.58984 | 15 | black | 16.796875 | 26 | 0.736938 | 0.468994 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 2 | 68 | 9.599609 | 108 | 28 | 37.79688 | 361.875 | 3.699707 | 1 | 1.399902 | 138 | 7.459961 | null | null | null | null | null | null | 2.402344 |
5,879 | 56.23798 | 0 | male | 0 | 7 | 1,991 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | null | under $11k | 0 | 10,796 | 8,250.9375 | 3,585.51953 | 13 | white | 20.597656 | 23 | 0.802979 | 0.681885 | 1 | 0 | 0 | no | null | null | no dnr | 7 | 72 | 15.5 | 52 | 25 | 36.29688 | null | 2.099609 | 1.399902 | 0.899902 | 140 | null | null | null | null | null | 2 | no(M2 and SIP pres) | 2 |
5,880 | 76.64899 | 1 | male | 0 | 7 | 94 | CHF | COPD/CHF/Cirrhosis | 5 | null | under $11k | 0 | 5,597 | 4,162.5547 | 1,534.0293 | 7 | white | 14.099609 | 33 | 0.858887 | 0.767944 | 1 | 0 | 0 | yes | null | null | no dnr | 7 | 103 | 7.199219 | 76 | 25 | 35.69531 | 283.875 | 3.399902 | 0.399963 | 1.099854 | 128 | 7.509766 | null | null | null | null | null | null | 2.806152 |
5,881 | 60.00497 | 1 | female | 0 | 9 | 1,552 | CHF | COPD/CHF/Cirrhosis | 5 | 9 | under $11k | 0 | 6,427 | 4,872.8867 | 1,547.40918 | 7.5 | black | 17.296875 | 27 | 0.872925 | 0.78894 | 1 | 1 | 0 | yes | 0.9 | 0.6 | no dnr | 9 | 105 | 7.799805 | 65 | 15 | 36.5 | 247.59375 | null | null | 1.699951 | 141 | 7.40918 | null | null | null | 0 | 0 | SIP>=30 | 0 |
5,882 | 37.89499 | 1 | male | 1 | 11 | 11 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 12 | under $11k | 0 | 35,796 | 26,760.6719 | 11,480.7266 | 50 | white | 38.398438 | 54 | 0.664917 | 0.56897 | 1 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 10 | 55 | 13.699219 | 113 | 32 | 38.09375 | 88.10938 | 2.599609 | 3.399902 | 0.599976 | 131 | 7.549805 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
5,883 | 54.92999 | 0 | male | 0 | 11 | 1,987 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | $25-$50k | 0 | 11,858 | 8,400.3438 | 4,436.59766 | 15 | white | 25.398438 | 35 | 0.820923 | 0.760986 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 11 | 71 | 11.599609 | 114 | 34 | 37.69531 | 167.5 | 2.399902 | 1.099854 | 0.699951 | 137 | 7.469727 | null | null | null | 0 | 1 | no(M2 and SIP pres) | 1 |
5,884 | 66.51099 | 1 | female | 0 | 7 | 802 | COPD | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 5,125 | 3,824.4434 | 1,248.62988 | 6.5 | black | 20.199219 | 34 | 0.85498 | 0.761963 | 1 | 0 | 0 | no | 0.99 | 0.99 | no dnr | 7 | 75 | 5.399414 | 73 | 25 | 35.09375 | 203.96875 | 3.699707 | 0.399963 | 1.199951 | 138 | 7.319336 | null | null | null | 0 | 1 | SIP>=30 | 1 |
5,885 | 61.28998 | 0 | female | 0 | 4 | 1,985 | CHF | COPD/CHF/Cirrhosis | 2 | 11 | under $11k | 0 | 2,292 | 1,767.9736 | 528.97998 | 10 | white | 19.097656 | 13 | 0.880981 | 0.800903 | 1 | 0 | 0 | no | 1 | 0.9 | no dnr | 4 | 73 | 5.399414 | 96 | 24 | 36 | 401.875 | 3.099609 | 0.599976 | 0.899902 | 138 | 7.419922 | null | null | null | 1 | null | no(M2 and SIP pres) | 1.1669 |
5,886 | 61.952 | 1 | female | 0 | 29 | 72 | ARF/MOSF w/Sepsis | ARF/MOSF | 5 | 11 | under $11k | 0 | 37,986 | 28,746.4062 | 10,535.4688 | 31.5 | black | 21.097656 | 37 | 0.851929 | 0.800903 | 1 | 1 | 0 | no | 0.7 | 0.65 | no dnr | 29 | 127 | 9.199219 | 107 | 30 | 37.89844 | 168.75 | 3.099609 | 1 | 1 | 136 | 7.469727 | null | null | null | null | 5 | adl>=4 (>=5 if sur) | 5 |
5,887 | 69.15295 | 0 | female | 0 | 4 | 1,984 | COPD | COPD/CHF/Cirrhosis | 1 | 12 | under $11k | 0 | 3,073 | 2,255.6621 | 987.70996 | 11 | white | 16.097656 | 34 | 0.884888 | 0.807983 | 1 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 4 | 61 | 3.5 | 64 | 32 | 36.29688 | 204.75 | 4 | 0.599976 | 0.699951 | 137 | 7.40918 | null | null | null | 1 | 1 | no(M2 and SIP pres) | 1 |
5,888 | 73.53296 | 1 | female | 1 | 20 | 20 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | $11-$25k | 0 | 251,017 | 187,147.5 | 75,303.3125 | 42.333313 | white | 23.097656 | 28 | 0.702881 | 0.612915 | 94 | 0 | 0 | no | 0.7 | 0.5 | dnr after sadm | 19 | 125 | 18.898438 | 118 | 9 | 36.69531 | 239.3125 | 1.899902 | 0.799927 | 0.799927 | 131 | 7.439453 | null | null | null | 3 | 0 | <2 mo. follow-up | 0 |
5,889 | 64.73395 | 1 | male | 0 | 12 | 35 | Colon Cancer | Cancer | 1 | 11 | $11-$25k | 0 | 9,608 | 7,434.043 | 3,044.12891 | 12 | white | 21.699219 | 31 | 0.744995 | 0.482971 | 1 | 0 | 0 | metastatic | 0.5 | 0.5 | no dnr | 12 | 110 | 7.199219 | 60 | 20 | 36 | null | null | 0.399963 | 6.699219 | 141 | null | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
5,890 | 72.14496 | 1 | female | 1 | 5 | 5 | MOSF w/Malig | ARF/MOSF | 2 | 12 | under $11k | 0 | 4,432 | 3,190.625 | 1,561.61914 | 24 | white | 26 | 24 | 0.570923 | 0.459961 | 1 | 0 | 0 | metastatic | 0.1 | 0.001 | dnr before sadm | -1 | 115 | 9.398438 | 106 | 30 | 36 | 418.5625 | 2.599609 | 0.199982 | 0.699951 | 126 | 7.209961 | null | null | null | null | 6 | <2 mo. follow-up | 6 |
5,891 | 67.59998 | 0 | female | 0 | 45 | 1,979 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | under $11k | 0 | 61,206 | 45,495.75 | 15,383.1328 | 26.25 | black | 40.296875 | 86 | 0.309998 | 0.197998 | 15 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 23 | 63 | 15.099609 | 140 | 40 | 35.39844 | 126.6875 | 1.899902 | 0.5 | 2.299805 | 129 | 7.449219 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
5,892 | 51.33698 | 1 | female | 0 | 42 | 181 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 66,895 | 50,142.4688 | 18,910.1562 | 17.5 | black | 20.097656 | 25 | 0.862915 | 0.772949 | 10 | 0 | 0 | no | 0.9 | 0.8 | no dnr | 42 | 68 | 8.099609 | 76 | 22 | 35.5 | null | 3.099609 | 0.399963 | 1.5 | 135 | null | null | null | null | 0 | null | null | 0.4948 |
5,893 | 56.14798 | 1 | male | 0 | 31 | 374 | MOSF w/Malig | ARF/MOSF | 3 | 12 | $25-$50k | 0 | 54,778 | 39,451.75 | 17,885.5156 | 26.25 | white | 31.898438 | 43 | 0.392944 | 0.273987 | 25 | 1 | 0 | yes | 0.7 | 0.3 | no dnr | 31 | 63 | 0.099991 | 120 | 24 | 38.5 | null | 3.099609 | 0.599976 | 0.899902 | 126 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
5,894 | 71.82196 | 0 | male | 0 | 9 | 1,977 | CHF | COPD/CHF/Cirrhosis | 3 | 0 | under $11k | 0 | 7,363 | 5,533.4102 | 1,675.3291 | 6 | black | 14.599609 | 23 | 0.86792 | 0.780884 | 1 | 0 | 0 | yes | 0.95 | 0.9 | no dnr | 9 | 60 | 5.699219 | 64 | 24 | 35.5 | 309.5 | 3.899902 | 0.699951 | 1 | 138 | 7.419922 | null | null | null | 2 | 0 | no(M2 and SIP pres) | 0 |
5,895 | 38.45599 | 0 | male | 0 | 43 | 1,977 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 62,292 | 48,560.375 | 18,525.4375 | 16.25 | white | 26.898438 | 21 | 0.735962 | 0.585938 | 22 | 1 | 0 | no | 0.9 | 0.6 | no dnr | 43 | 82 | 13 | 122 | 22 | 38 | 403.3125 | 3.299805 | 4.099609 | 0.5 | 131 | 7.449219 | null | null | null | null | 7 | adl>=4 (>=5 if sur) | 7 |
5,896 | 69.51099 | 0 | male | 0 | 4 | 1,976 | CHF | COPD/CHF/Cirrhosis | 7 | 9 | $11-$25k | 0 | 2,553 | 1,985.8906 | 672.65967 | 6 | white | 17.796875 | 25 | 0.800903 | 0.678955 | 1 | 1 | 0 | metastatic | 0.99 | 0.95 | no dnr | 4 | 73 | 6.399414 | 58 | 20 | 36 | null | 3.399902 | 0.399963 | 1.199951 | 135 | null | null | null | null | 1 | null | no(M2 and SIP pres) | 1.1669 |
5,897 | 74.21198 | 1 | female | 1 | 3 | 3 | MOSF w/Malig | ARF/MOSF | 4 | 8 | under $11k | 100 | 8,157 | 6,242.8867 | 2,263.73828 | 34 | white | 79.59375 | 75 | 0 | 0 | 3 | 1 | 0 | metastatic | 0.05 | 0.000125 | no dnr | 3 | 0 | 2.799805 | 0 | 0 | 39 | 99.15625 | 2.599609 | 1.199951 | 1 | 137 | 7.289062 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
5,898 | 64.81299 | 1 | female | 0 | 12 | 488 | CHF | COPD/CHF/Cirrhosis | 4 | 9 | under $11k | 0 | 9,217 | 7,024.7773 | 2,455.71875 | 10.5 | hispanic | 19.699219 | 30 | 0.865967 | 0.777954 | 1 | 1 | 0 | no | 0.8 | 0.7 | no dnr | 12 | 58 | 8.699219 | 44 | 16 | 36.09375 | null | 3.599609 | 1.099854 | 1 | 140 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
5,899 | 58.21997 | 0 | male | 0 | 6 | 1,976 | Lung Cancer | Cancer | 2 | 14 | under $11k | 0 | 4,723 | 3,596.1172 | 1,580.91992 | 10 | white | 6.199219 | 9 | 0.873901 | 0.716919 | 1 | 0 | 0 | metastatic | 1 | 1 | no dnr | 6 | 87 | 11.199219 | 72 | 16 | 36.59375 | 238.09375 | 4.299805 | null | 1 | 140 | 7.40918 | null | null | null | 0 | null | null | 0.4948 |
5,900 | 46.98398 | 1 | female | 1 | 4 | 4 | MOSF w/Malig | ARF/MOSF | 2 | 12 | null | 100 | 2,358 | 1,865.3467 | 470.62988 | 24 | white | 29.296875 | 41 | 0.122986 | 0.054993 | 1 | 0 | 0 | yes | 0 | 0 | dnr before sadm | -1 | 79 | 2.199707 | 124 | 36 | 38.79688 | null | 2.699707 | 0.799927 | 1.099854 | 130 | null | null | null | null | null | 4 | <2 mo. follow-up | 4 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.